CMS announced a proposed federal rule to tighten oversight of organ procurement organizations, including stronger recertification standards and performance accountability. The proposal is aimed at improving patient protections and the quality of organ recovery and transplantation services. If finalized, the rule would update how CMS evaluates OPOs and could affect certification status for organizations that fail to meet federal benchmarks.
